10.3205/13DGCH682
Bazhin, Alexandr
Alexandr
Bazhin
Bleul, Tim
Tim
Bleul
Büchler, Markus W.
Markus W.
Büchler
Werner, Jens
Jens
Werner
Retinoid receptors in pancreatic cancer
German Medical Science GMS Publishing House
2013
ConferencePaper
610 Medical sciences; Medicine
Deutsche Gesellschaft Für Chirurgie
2013-04-26
2013
de
urn:nbn:de:0183-13dgch6823
13dgch682
text/html
130. Kongress der Deutschen Gesellschaft für Chirurgie
Introduction: Pancreatic adenocarcinoma (PDAC) has a particularly poor prognosis with a median survival of 6 months. The standard treatment today is surgical resection and subsequent adjuvant chemotherapy. This is possible in about 20% of all patients, and results in a median survival of over 20[for full text, please go to the a.m. URL]
130. Kongress der Deutschen Gesellschaft für Chirurgie